Kezar Life Sciences, Inc.KZRNASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank78
3Y CAGR+0.7%
5Y CAGR+14.6%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+0.7%/yr
vs +32.2%/yr prior
5Y CAGR
+14.6%/yr
Recent deceleration
Acceleration
-31.5pp
Decelerating
Percentile
P78
Within normal range
vs 5Y Ago
2x
Strong expansion
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $20.58M | -12.0% |
| 2024 | $23.39M | -11.9% |
| 2023 | $26.54M | +31.7% |
| 2022 | $20.15M | +28.2% |
| 2021 | $15.72M | +50.8% |
| 2020 | $10.43M | +20.1% |
| 2019 | $8.68M | +31.7% |
| 2018 | $6.59M | +189.0% |
| 2017 | $2.28M | +41.0% |
| 2016 | $1.62M | - |